NO308902B1 - Nye kinoksalindionderivater og anvendelse i legemidler - Google Patents

Nye kinoksalindionderivater og anvendelse i legemidler

Info

Publication number: NO308902B1
Authority: NO; Norway
Prior art keywords: substd; opt; halo; phenyl; new
Prior art date: 1993-04-28

Application number

NO954315A

Other languages

English (en)

Norwegian (no)

Other versions

NO954315D0 (no

NO954315L (no

Inventor

Andreas Huth

Lechoslaw Turski

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-28

Filing date

1995-10-27

Publication date

2000-11-13

1993-04-28 Priority claimed from DE4314591A external-priority patent/DE4314591A1/de

1993-12-21 Priority claimed from DE19934344486 external-priority patent/DE4344486A1/de

1995-10-27 Application filed by Schering Ag filed Critical Schering Ag

1995-10-27 Publication of NO954315D0 publication Critical patent/NO954315D0/no

1995-12-28 Publication of NO954315L publication Critical patent/NO954315L/no

2000-11-13 Publication of NO308902B1 publication Critical patent/NO308902B1/no

Links

239000003814 drug Substances 0.000 title 1
125000005843 halogen group Chemical group 0.000 abstract 6
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
125000000217 alkyl group Chemical group 0.000 abstract 3
125000000623 heterocyclic group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 2
125000002883 imidazolyl group Chemical group 0.000 abstract 2
YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 abstract 2
125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
125000004430 oxygen atom Chemical group O* 0.000 abstract 2
125000004434 sulfur atom Chemical group 0.000 abstract 2
229910006069 SO3H Inorganic materials 0.000 abstract 1
125000004429 atom Chemical group 0.000 abstract 1
125000001072 heteroaryl group Chemical group 0.000 abstract 1
SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical compound C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000003831 tetrazolyl group Chemical group 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
- C07F9/650994—Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Peptides Or Proteins (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

NO954315A 1993-04-28 1995-10-27 Nye kinoksalindionderivater og anvendelse i legemidler NO308902B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE4314591A DE4314591A1 (de)	1993-04-28	1993-04-28	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19934344486 DE4344486A1 (de)	1993-12-21	1993-12-21	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
PCT/DE1994/000493 WO1994025469A1 (de)	1993-04-28	1994-04-28	Neue chinoxalindionderivative, deren herstellung und verwendung in arzneimitteln

Publications (3)

Publication Number	Publication Date
NO954315D0 NO954315D0 (no)	1995-10-27
NO954315L NO954315L (no)	1995-12-28
NO308902B1 true NO308902B1 (no)	2000-11-13

Family

ID=25925529

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO954315A NO308902B1 (no)	1993-04-28	1995-10-27	Nye kinoksalindionderivater og anvendelse i legemidler
NO20001604A NO311428B1 (no)	1993-04-28	2000-03-28	Nye kinoksalindionderivater og legemidler inneholdende disse

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20001604A NO311428B1 (no)	1993-04-28	2000-03-28	Nye kinoksalindionderivater og legemidler inneholdende disse

Country Status (23)

Country	Link
US (2)	US5750525A (cs)
EP (2)	EP0696288B1 (cs)
JP (1)	JP3530190B2 (cs)
KR (1)	KR100293880B1 (cs)
CN (1)	CN1053190C (cs)
AT (1)	ATE196474T1 (cs)
AU (1)	AU690550B2 (cs)
CA (1)	CA2161425A1 (cs)
CZ (1)	CZ290295B6 (cs)
DE (1)	DE59409534D1 (cs)
DK (1)	DK0696288T3 (cs)
ES (1)	ES2150989T3 (cs)
FI (1)	FI955140A (cs)
GR (1)	GR3035053T3 (cs)
HU (1)	HUT73676A (cs)
IL (1)	IL109397A0 (cs)
NO (2)	NO308902B1 (cs)
NZ (1)	NZ265599A (cs)
PL (1)	PL180332B1 (cs)
PT (1)	PT696288E (cs)
RU (1)	RU2140420C1 (cs)
SK (1)	SK282851B6 (cs)
WO (1)	WO1994025469A1 (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6057304A (en) *	1992-10-26	2000-05-02	Schering Aktiengesellschaft	Quinoxaline-phosphonic acid derivatives
PT647137E (pt) *	1992-06-22	2008-11-24	Univ California	Antagonistas dos receptores da glicina e a sua utilização
HU217837B (hu) *	1994-05-18	2000-04-28	EGIS Gyógyszergyár Rt.	Savamidok, ezeket tartalmazó gyógyászati készítmények és eljárás a hatóanyagok előállítására
GB9419318D0 (en) *	1994-09-24	1994-11-09	Pfizer Ltd	Therapeutic agents
ATE209644T1 (de) *	1994-09-27	2001-12-15	Yamanouchi Pharma Co Ltd	1,2,3,4-tetrahydroquinoxalindion derivate und ihre verwendung als glutamat rezeptor antagonisten
DE4439493A1 (de) *	1994-10-25	1996-05-02	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE4439492A1 (de) *	1994-10-25	1996-05-02	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19519979A1 (de) *	1995-05-24	1996-11-28	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
CA2224718A1 (en) *	1995-07-10	1997-01-30	Novartis Ag	Novel quinoxaline- and quinoxalinylalkane-phosphonic acids
DE19545251A1 (de) *	1995-11-24	1997-05-28	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
TW448171B (en) *	1996-06-06	2001-08-01	Yamanouchi Pharma Co Ltd	Imidazole-substituted quinoxalinedione derivatives
AU733896B2 (en) *	1996-10-23	2001-05-31	Warner-Lambert Company	Substituted gamma aminobutyric acids as pharmaceutical agents
RU2181362C2 (ru) *	1996-10-24	2002-04-20	Новартис Аг	Производные аминофосфоновых и -фосфиновых кислот, способ их получения и фармацевтические составы на их основе
DE19728326A1 (de) *	1997-06-27	1999-01-07	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
DE19737446A1 (de) *	1997-08-22	1999-02-25	Schering Ag	Verfahren zur Herstellung von Phosphonsäurederivaten
KR100588247B1 (ko) *	1997-09-01	2006-06-13	교린 세이야꾸 가부시키 가이샤	6,7-비대칭 이치환된 퀴녹살린카복실산 유도체와 이의부가염 및 이들의 제조방법
US6015800A (en) *	1997-09-03	2000-01-18	Warner-Lambert Company	Substituted quinoxaline-2-ones as glutamate receptor antagonists
EP1100504A2 (en) *	1998-07-02	2001-05-23	Eisai Co., Ltd.	Pharmaceutical compositions and their uses for treatment of demyelinating disorders
DE60027546T2 (de)	1999-02-15	2007-04-26	Eisai Co., Ltd.	Heterodiazinon-derivate
FR2791982B1 (fr) *	1999-04-06	2002-12-27	Inst Nat Sante Rech Med	Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques.
EP2177520A1 (en)	2000-06-12	2010-04-21	Eisai R&D Management Co., Ltd.	1,5-Di(aryl or heteroaryl)-3-halo-2(1H)-pyridones as intermediates for the preparation of AMPA receptor inhibitors
GB0129260D0 (en)	2001-12-06	2002-01-23	Eisai London Res Lab Ltd	Pharmaceutical compositions and their uses
MY148809A (en)	2004-07-06	2013-05-31	Eisai R&D Man Co Ltd	Crystals of 1,2-dihydropyridine compound and their production process
CN100490835C (zh) *	2004-12-14	2009-05-27	朱木林	一种治疗骨折的药物
EP2338492A1 (en)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Methods and compositions for the treatment of alzheimer
MX2021006317A (es)	2018-12-14	2021-08-11	Eisai R&D Man Co Ltd	Formulaciones farmaceuticas de base acuosa de compuestos de 1,2-dihidropiridina.
CN112142797B (zh) *	2020-09-11	2023-07-14	江西师范大学	含磷的喹喔啉类化合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO179551C (no) *	1987-11-10	1996-10-30	Novo Nordisk As	Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
IL90315A0 (en) *	1988-06-01	1989-12-15	Ferrosan As	Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them
DK69790D0 (da) *	1990-03-16	1990-03-16	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling af anvendelse
ATE194985T1 (de) *	1990-11-06	2000-08-15	Yamanouchi Pharma Co Ltd	Kondensiertes pyrazinderivat
PT101004B (pt) *	1991-10-26	1999-10-29	Schering Ag	Derivados da quinoxalina, processo para a sua preparacao e composicoes farmaceuticas que os contem
PT647137E (pt) *	1992-06-22	2008-11-24	Univ California	Antagonistas dos receptores da glicina e a sua utilização

1994
- 1994-04-22 IL IL10939794A patent/IL109397A0/xx unknown
- 1994-04-28 EP EP94914313A patent/EP0696288B1/de not_active Expired - Lifetime
- 1994-04-28 SK SK1318-95A patent/SK282851B6/sk unknown
- 1994-04-28 EP EP00250046A patent/EP1002796A3/de not_active Withdrawn
- 1994-04-28 PL PL94317075A patent/PL180332B1/pl not_active IP Right Cessation
- 1994-04-28 DK DK94914313T patent/DK0696288T3/da active
- 1994-04-28 CZ CZ19952828A patent/CZ290295B6/cs not_active IP Right Cessation
- 1994-04-28 DE DE59409534T patent/DE59409534D1/de not_active Expired - Lifetime
- 1994-04-28 WO PCT/DE1994/000493 patent/WO1994025469A1/de active IP Right Grant
- 1994-04-28 AT AT94914313T patent/ATE196474T1/de not_active IP Right Cessation
- 1994-04-28 ES ES94914313T patent/ES2150989T3/es not_active Expired - Lifetime
- 1994-04-28 JP JP52375194A patent/JP3530190B2/ja not_active Expired - Fee Related
- 1994-04-28 RU RU95120088A patent/RU2140420C1/ru not_active IP Right Cessation
- 1994-04-28 AU AU66755/94A patent/AU690550B2/en not_active Ceased
- 1994-04-28 NZ NZ265599A patent/NZ265599A/en unknown
- 1994-04-28 US US08/537,839 patent/US5750525A/en not_active Expired - Fee Related
- 1994-04-28 HU HU9503078A patent/HUT73676A/hu unknown
- 1994-04-28 CN CN94191917A patent/CN1053190C/zh not_active Expired - Fee Related
- 1994-04-28 CA CA002161425A patent/CA2161425A1/en not_active Abandoned
- 1994-04-28 KR KR1019950704705A patent/KR100293880B1/ko not_active IP Right Cessation
- 1994-04-28 PT PT94914313T patent/PT696288E/pt unknown
1995
- 1995-10-27 FI FI955140A patent/FI955140A/fi not_active Application Discontinuation
- 1995-10-27 NO NO954315A patent/NO308902B1/no not_active IP Right Cessation
1997
- 1997-12-12 US US08/989,779 patent/US5955461A/en not_active Expired - Fee Related
2000
- 2000-03-28 NO NO20001604A patent/NO311428B1/no not_active IP Right Cessation
- 2000-12-12 GR GR20000402741T patent/GR3035053T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
US5750525A (en)	1998-05-12
HU9503078D0 (en)	1995-12-28
DE59409534D1 (de)	2000-10-26
CZ290295B6 (cs)	2002-07-17
ES2150989T3 (es)	2000-12-16
FI955140A0 (fi)	1995-10-27
NO20001604D0 (no)	2000-03-28
CA2161425A1 (en)	1994-11-10
EP0696288B1 (de)	2000-09-20
FI955140A (fi)	1995-10-27
EP1002796A3 (de)	2001-09-12
CZ282895A3 (en)	1996-02-14
GR3035053T3 (en)	2001-03-30
JP3530190B2 (ja)	2004-05-24
EP1002796A2 (de)	2000-05-24
SK282851B6 (sk)	2002-12-03
PL317075A1 (en)	1997-03-03
WO1994025469A1 (de)	1994-11-10
SK131895A3 (en)	1996-07-03
NO954315D0 (no)	1995-10-27
PT696288E (pt)	2001-01-31
KR100293880B1 (ko)	2001-09-17
DK0696288T3 (da)	2000-11-13
PL180332B1 (pl)	2001-01-31
AU690550B2 (en)	1998-04-30
CN1153517A (zh)	1997-07-02
CN1053190C (zh)	2000-06-07
IL109397A0 (en)	1994-07-31
US5955461A (en)	1999-09-21
NO954315L (no)	1995-12-28
EP0696288A1 (de)	1996-02-14
NZ265599A (en)	1997-10-24
HUT73676A (en)	1996-09-30
RU2140420C1 (ru)	1999-10-27
NO20001604L (no)	1995-12-28
JPH08508037A (ja)	1996-08-27
AU6675594A (en)	1994-11-21
ATE196474T1 (de)	2000-10-15
NO311428B1 (no)	2001-11-26

Legal Events

Date	Code	Title	Description
2005-11-28	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20001604D0 (no)	2000-03-28	Nye kinoksalindionderivater og anvendelse i legemidler
ATE137228T1 (de)	1996-05-15	Aminocarbonsäure und derivate
TR24136A (tr)	1991-04-04	Ikameli tiyazollar ve bunlarin fungisitler yerine kullanimi
MX9203262A (es)	1992-07-01	Agentes quelantes del acido 1,4,7,10-tetraazaciclododecano.
FI934366A (fi)	1993-10-05	Atp-analoger
DK705888A (da)	1989-08-13	Pyridazinonderivater
NO933425L (no)	1993-10-25	Nye aktive forbindelser
DK0477778T3 (da)	1996-06-24	Benzen-, pyridin- eller pyrimidinderivat
SE8303987L (sv)	1984-01-16	N-fenylpyrazolderivat anvendbara som herbicider
GB997037A (en)	1965-06-30	New hydrantoin derivatives
ES8301196A1 (es)	1982-11-16	Procedimiento de preparacion de un nuevo derivado de acido cinamoil-cinamico
FI955670A (fi)	1996-05-26	2-aminobentseenisulfonihappo- ja 2-aminobentseenisulfonyyli kloridijohdannaiset, niiden valmistus ja käyttö synteesin välituotteina
NO306293B1 (no)	1999-10-18	Benzoylguanidiner, deres anvendelse for fremstilling av legemiddel eller diagnostikum sÕvel som medikamenter inneholdende dem
AU1659192A (en)	1992-12-30	Novel 2h-benzo(b)pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
PT87364A (pt)	1989-05-31	Process for preparing herbicides compounds comprising anilide
DE59002904D1 (de)	1993-11-04	Cyclopropanthiocarbonsaeureamide.
FR2312495A1 (fr)	1976-12-24	Esters ou ethers de 1-hydroxy-2(1,1-difluoroalkyl)-benzimidazoles pesticides